Vr Adviser, LLC Aclaris Therapeutics, Inc. Transaction History

Vr Adviser, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $24.9 Million - $63.2 Million	-3,523,208 Reduced 77.2%	1,040,754 $8.42 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $14.4 Million - $25 Million	843,380 Added 22.67%	4,563,962 $80.1 Million
Q1 2021 May 14, 2021	BUY	$5.86 - $27.73 $10.3 Million - $49 Million	1,765,650 Added 90.32%	3,720,582 $93.8 Million
Q4 2020 Feb 12, 2021	BUY	$2.65 - $7.61 $5.18 Million - $14.9 Million	1,954,932 New	1,954,932 $12.6 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.